New ISOLED-D™ line delivers premium, scalable deuterated reagents for OLED synthesis, supporting the industry from R&D through commercial production with CIL's global manufacturing and expertise.

TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / May 20, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), the global leader in stable isotope-labeled products, announces the launch of ISOLED-D™, a groundbreaking line of deuterated reagents specifically designed for organic light-emitting diode (OLED) synthesis. ISOLED-D LOGO

ISOLED-D LOGO
ISOLED-D - deuterated reagents specifically designed for organic light-emitting diode

ISOLED-D represents a significant advancement in OLED manufacturing technology, offering high-quality deuterated reagents with manufacturing in state-of-the-art, strategically located worldwide facilities. The product line caters to various production scales, from gram quantities for research and development to metric-ton volumes for full-scale commercial manufacturing.

"ISOLED-D demonstrates our commitment to advancing OLED technology through innovative isotope-labeled solutions," said Tasha Agreste, Business Development Manager for Deuterated Reagents at CIL. "Our ability to scale production from laboratory to industrial quantities positions us as a crucial partner in the OLED manufacturing ecosystem."

The company's flexible approach enables seamless collaboration with research and development teams through to commercial production, ensuring consistent quality and reliable supply chains for manufacturers in the rapidly growing OLED market.

Key features of ISOLED-D:

Premium-grade deuterated reagents for OLED synthesis
Scalable production capabilities from grams to metric tons
Manufacturing in state-of-the-art facilities
Complete R&D to commercialization support
Backed by CIL's industry-leading expertise in stable isotope-labeled products
Deuterated Benzene Recovery program

For more information about ISOLED-D and CIL's complete range of isotope-labeled products, visit isotope.com.

Contact Information

Crissy Krisko
crissyk@isotope.com
1.978.269.1930

SOURCE: Cambridge Isotope Laboratories, Inc.

View the original press release on ACCESS Newswire

Logo

Images

Tags

More Like This

CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers

Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production

Cambridge Isotope Laboratories, Inc. Launches 12C Methane QG Diamond for Quantum Applications

Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase

Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project

Isotopia Announces Official Commercial Launch of Isoprotrace® in Germany in Partnership with DSD Pharma

Medical Device First to Enter the European Market with Sustainable, Innovative Sterilization Approach with Chlorine Dioxide Gas

Notice of Commencement of Operation of Dexerials Photonics Solutions Corporation as Integrated Company Leading Growth in the Photonics Domain